- UCL Institute of Neurology Professor John Hardy is first UK winner of $3m Breakthrough Prize in Life Sciences
- MRC Centre-BRC MRI Biomarker Collaboration in Lancet Neurology: Important implications for experimental trials in Neuromuscular Diseases
- Movement Making and Action Potential: collaborations raising awareness of Motor Neuron Disease
- Being moody may help us adapt to change
- Landmark study tests whether immunotherapy drugs can prevent onset of symptoms in patients at high risk of developing Alzheimer’s
- UCL Institute of Neurology hosts inaugural Ada Lovelace Day event
- First human trial for innovative new drug in development to treat Huntington’s disease
- UCL and UK supermarkets unite to beat dementia
- Possible evidence for human transmission of Alzheimer’s pathology
- GABA neurotransmitter may be progressive MS marker
- Piepenbrock Group and German Center for Neurodegenerative Diseases honour Professor Hardy
- Compensation in Huntington’s disease
- Novel conceptual framework for tackling the global challenge of dementia
- BRC funding for experimental medicine research projects
- Researchers identify genetic links between epilepsy and sudden death
- Landmark 69-year study to provide window into dementia
- Study of brain changes 20 years before hereditary dementia symptoms start
- Dopamine drugs affect risk taking behaviour and happiness
- Commonly prescribed drugs affect decisions to harm oneself and others
- Research reveals how the human brain might reconstruct past events
- Research into genetic influences on epilepsy and migraines
- Fast forwarding treatment for neurodegenerative disorders at LWENC
- Natural genetic variation gives complete resistance in prion diseases
- Professor Lees awarded ABN Medal 2015
- Professor Hardy elected member of EMBO
- Working with Saracens to monitor concussion in rugby
- Mutations in two novel genes cause primary dystonia
- A new genetic switch uncovered in the long genes expressed in our brain
- Professor Alan Thompson elected to the Fellowship of the Academy of Medical Sciences
- UCL Institute of Neurology researchers awarded MRC fellowships
- Professor Ray Dolan has been elected Member of the European Academy of Sciences and Arts
- Deep brain stimulation for Tourette syndrome
- Behaviour changes common in early stage familial Alzheimer's
- Imaging shows early brain changes in FTD patients
- New test measures deadly protein in Huntington’s disease patients’ spinal fluid
- Professor Mary Reilly is elected to be the first female President of the Association of British Neurologists in 83 years
- Structure of genetic messenger molecules reveals key role in diseases
- Professor Nick Fox speaks about trial in early onset familial Alzheimer's disease at UCL
- First major exhibition to explore BSE and its impact opens at Hayward Gallery
- Government pledges £300m for dementia research
- UCL awarded £10m to develop new dementia treatments
- BRC awards £700,000 to neuroscience projects
- Acute optic neuritis: a review and proposed protocol
- Teaching Awards 2015
29 July 2010
We are delighted to congratulate two researchers based at Queen Square, Dr Paul Bays (IoN Department of Brain Repair and Rehabilitation) and Dr Fiona McNab (Wellcome Department of Imaging Neuroscience), on being awarded Wellcome Trust Career Development Fellowships.
The Wellcome Career Development Fellowship scheme provides an opportunity for postdoctoral scientists from across the remits of the Wellcome Trust's funding streams to become independent research scientists and undertake high-quality research.
Described by the Director of the Institute, Professor Alan Thompson as "the icing on the cake", Dr Bays has also been awarded the highly prestigious Wellcome-Beit Prize Fellowship, in recognition of the exceptional quality of his Fellowship application. This award provides additional recognition for just four outstanding biomedical researchers who have been awarded other Wellcome Trust fellowship funding across all fields.
Professor Jon Driver said, "UCL is very fortunate to be able to attract leading young scientists of the exceptional calibre of Paul Bays and Fiona McNab".
Dr Bays will conduct research on attention, working memory and action in the normal and damaged brain, building on his recent studies published in Science and in the Journal of Neuroscience.
Dr McNab has an exciting plan for studying the impact of ageing, dopaminergic modulation, and scientifically-informed cognitive training on working memory. Her work promises not only to shed light on the brain basis of cognitive function, but also to identify new ways to mitigate against cognitive decline in the elderly.
Professor Masud Husain, Head of the Department of Brain Repair and Rehabilitation commented "It's fantastic to see such talented individuals being supported in applying basic neuroscience to clinically important questions."
Page last modified on 28 jul 10 17:36